Re-Imagining Medical Research Is Now an Imperative
February 11, 2025
Re-Imagining Medical Research Is Now an Imperative
Effective February 10, the U.S. government will cut medical research grants by at least $4 billion. 1 This is only one part of an accelerating trend in reducing healthcare expenditures – often by utilizing modern technology. 2
The National Institutes of Health provide funding to thousands of hospitals, medical schools, universities, and independent research organizations. They in turn support more than 300,000 researchers. 3
In many cases, medical science can advance only through expensive laboratories, hundreds of researchers, and associated overhead. In many more cases however, true improvement in healthcare results from letting physicians not researchers lead the way. In other words, the most impactful clinical research is usually developed from the bottom up, not the top down.
Today, as in the past, practicing physicians can generate the best informed and therefore most impactful clinical hypotheses. Physicians are an immensely valuable resource which our current approach to medical research fails to utilize. Even in large academic medical institutions, there is a broad divide between research and everyday clinical practice. 4 This is one more reason America spends far more than any other country on healthcare, with generally worse results. 5
RegenMed provides the technical platforms and burden-free processes allowing physicians in any specialty, wherever located, to collaborate on medical research. Medical research which is statistically significant, and can have a positive and broad impact today.
Critically, RegenMed delivers these capabilities to physicians and partnering scientists at a far lower price, and with far less burden, than current approaches. It is thus in a strong position to help healthcare institutions deliver genuine value-based medicine.
Contact us to learn more.
Re-Imagining Medical Research Is Now an Imperative
February 11, 2025
Effective February 10, the U.S. government will cut medical research grants by at least $4 billion. 1 This is only one part of an accelerating trend in reducing healthcare expenditures – often by utilizing modern technology. 2
The National Institutes of Health provide funding to thousands of hospitals, medical schools, universities, and independent research organizations. They in turn support more than 300,000 researchers. 3
In many cases, medical science can advance only through expensive laboratories, hundreds of researchers, and associated overhead. In many more cases however, true improvement in healthcare results from letting physicians not researchers lead the way. In other words, the most impactful clinical research is usually developed from the bottom up, not the top down.
Today, as in the past, practicing physicians can generate the best informed and therefore most impactful clinical hypotheses. Physicians are an immensely valuable resource which our current approach to medical research fails to utilize. Even in large academic medical institutions, there is a broad divide between research and everyday clinical practice. 4 This is one more reason America spends far more than any other country on healthcare, with generally worse results. 5
RegenMed provides the technical platforms and burden-free processes allowing physicians in any specialty, wherever located, to collaborate on medical research. Medical research which is statistically significant, and can have a positive and broad impact today.
Critically, RegenMed delivers these capabilities to physicians and partnering scientists at a far lower price, and with far less burden, than current approaches. It is thus in a strong position to help healthcare institutions deliver genuine value-based medicine.
Contact us to learn more.
1 Trump administration to cut billions from overheads in biomedical research
2 Overstretched healthcare should welcome the rise of the AI body scan
3 For details see NIH Awards by Location & Organization
4 There are challenges when translating research to practice.
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles.
Can we streamline the concepts of knowledge translation, dissemination and implementation for lay stakeholders? A perspective.
Bridging the research–practice gap in healthcare: a rapid review of research translation centres in England and Australia